Court Rejects Personalized Medicine Patents

March 21, 2012 | The US Supreme Court rejected two Prometheus patents on a method for monitoring a patient's blood to determine drug dosing. Mayo Clinic brought the patent challenge. The Supreme Court ruled that adjusting dosage based on patient monitoring was a natural process and could not be patented. The decision could threaten hundreds of patents and possibly the future of personalized medicine, some biotech representatives warned. Chicago Tribune
Click here to login and leave a comment.  


Add Comment

Text Only 2000 character limit

Page 1 of 1